New two-drug attack on spreading colon cancer enters testing
NCT ID NCT07355764
Summary
This study is testing if a new drug called SHR-1811, when combined with an existing drug (bevacizumab), can help control advanced colorectal cancer that has spread and worsened after standard first treatment. It will involve about 80 adults whose cancer has a certain level of a protein called HER2. Researchers will measure if the tumors shrink and how long the cancer stays under control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TARGETED THERAPY are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.